HEALTH PROGRESS

SELENIUM-BASED NANOCAPSULES

LAB PROBES

Groundbreaking Nanomedicine Research by NEOSETAC Set to Revolutionize Breast Cancer Treatment

Barcelona, Spain - 27/9/23 In a pivotal moment for medical research and innovation, the NEOSETAC project, an esteemed initiative under the Horizon 2020 Marie Skłodowska-Curie Actions Research and Innovation Staff Exchange Programme, has proudly concluded its final...

Final Newsletter and Milestones Achieved

We are thrilled to announce the release of the final newsletter of the NEOSETAC project, a groundbreaking initiative that has advanced the field of nanomedicine in cancer research. The project, funded by the European Union, has successfully brought together experts...

NEOSETAC Final Workshop

Introduction: In the ever-evolving field of medicine, nanotechnology has emerged as a promising avenue for revolutionizing cancer research and treatment. To shed light on the latest advancements in this field, the NEOSETAC project proudly announces the 4th...

NEOSETAC third newsletter

We are excited to announce that NEOSETAC, a trailblazing initiative focusing on the anti-cancer therapeutic potential of a novel selenium-based therapy for managing breast cancer, has launched its third newsletter. The newsletter is packed with insightful updates,...

NEOSETAC Promotes EU Missions’ Success in Paving the Way towards a Greener and Healthier Future

The NEOSETAC project has taken a significant stride towards achieving its objectives by aligning with the European Union's groundbreaking Missions in Horizon Europe. The latest announcement by the EU Commission highlights the notable contribution of these missions in...

Scientific Synergy: Valiente and Corradini Unite in Rome

Groundbreaking Collaboration and Meeting Between Prof. Manuel Valiente and Prof. Danilo Corradini in Rome: Fueling Scientific Advancement and International Cooperation Prof. Manuel Valiente with Prof Danilo Corradini in Rome Exciting collaboration and meeting between...

Successful Secondment at Karolinska Hospital for UAB researcher

Javier Gutierrez Successfully Completes 3-Month Secondment to Karolinska Hospital NEOSETAC Project Shows Promise in Novel Selenium-based Therapy for Breast Cancer Javier Gutierrez We are thrilled to announce that Javier Gutierrez from the Universitat Autonoma de...

The Karolinska Institute Innovation Ecosystem for Cancer Startups: Lessons Learned and Best Practices

The NEOSETAC project, which focuses on demonstrating the therapeutic potential of a novel Selenium-based therapy for managing breast cancer, will be interested in a recent article published in Insights into Regional Development. Titled "The Karolinska Institute...

Innovating Cancer Research: Exploring New Frontiers through Collaboration and Entrepreneurship

The REDINN secondment program at Karolinska Institute is focused on exploring and implementing innovative approaches to managing cancer research and fostering collaborations between start-ups and the research community. In this article, we will discuss the critical...

NEOSETAC UAB Secondments in Austria: Building Bridges between Academia and Industry

NEOSETAC recently organized a secondment program for Prof Manuel Valiente and Prof. Maria Jesus Sanchez from the Universitat Autònoma de Barcelona (UAB) in Innsbruck, Austria. This secondment was a month-long experience of collaboration with the ASDI. ADSI was founded...

Subscribe to our Newsletter

7 + 12 =